Bracco Imaging and Arrayus Technologies: a new strategic partnership Bracco Imaging and Arrayus Technologies have partnered to improve drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.

AI Pills in Medical Writing This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.

Gadopiclenol receives the JFR 2024 Innovation Award Bracco Imaging is delighted to announce that Gadopiclenol (marketed as Vueway® by Bracco) has been honored with the JFR 2024 Innovation Award in the Jury's Favorite category.

Vuebox: Support Fuji Non-ASR systems, currently supported for Fuji

Bracco Diagnostics and Subtle Medical Announce FDA Clearance of AiMIFY™ Software Bracco Diagnostics Inc. and Subtle Medical, Inc. are thrilled to announce that their collaborative AI-powered software, AiMIFYTM, has received FDA clearance as a Class II software as a medical device (SaMD) for magnetic resonance imaging (MRI) of the brain.

Hexagon: A new era begins With the inauguration of Hexagon, Bracco unveils its new cutting-edge manufacturing facility in Plan-les-Ouates, Geneva, Switzerland, making a significant milestone in the company's long history of innovation.

Bracco triples production of its innovative ultrasound contrast agent in Geneva Over 80 million euros has been invested to build Hexagon, a new manufacturing facility located next to the historical 1996 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco's research.

EuSoMII/Bracco AI Contest EuSoMII/Bracco together for the 2025 AI Contest

Webinar: Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS We are pleased to invite you to join an educational webinar entitled Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS scheduled for January 15 from 6:00 to 7:00 pm CET.

ECR2025 Bracco@ECR2025, Our journey to the future continues today, together. For a sustainable tomorrow.